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REFERENCE data for eventual comparison of the spontaneous incidence of
mammary carcinoma in C3H,/Pu female mice (Pullinger and Iversen, 1960)
with that to be seen after substitution ofgraded amounts of ovarian oestrogenic
hormones have been recorded. Before these substitutions could be undertaken
it was also necessary to examine this strain for presence or absence ofthe mammary
tumour agent discovered by Bittner. No evidence ofinfection with the agent was
found among the forebears by Heston and his colleagues (Heston, 1958), nor has
any been detected in this laboratory. Evidence has been sought for in-breeding
records, from injections of spleen and tumour extracts, by attempts at forced
activation of the pathogenic action of the agent and by cross-suckling new-born
RIII, mice on C3H, nursing mothers.
MATERIALS AND METHODS
The source, management and methods of examination of the the two strains
have been described (Pullinger and Iversen, 1960).
Detection of the mammary tumour agent
If the agent is present in small amount the infection may not be revealed by
mammary carcinoma in one generation of mothers but only in breeders of suc-
ceedinggenerations (Andervont, 1950). Thus the most reliablebiological criterion
for judging absence of agent is considered to be failure to find an accumulation
of mammary carcinomas in sublines in breeders observed through several genera-
tions (Heston, 1958). When the agent is present in greater amounts, whether by natural infection or by injection of extracts oftissues or tumours, its pathological
action is readily revealed in susceptible agent-free females after breeding. No
objective measure of the amount of agent is available. The origin and pedigree records ofthe mice used fortesting must be free ofsuspicion that they themselves
are carrying thisagent. TheRIII/ strain has been used for this purpose, hence the
need to examine recent breeding records.
Since Bagg's functional or force-breeding test was introduced (Bagg and
Jacksen, 1937) it has been considered necessary by some workers either to force-
breed the mothers in order to cause milkstagnation, or, byothers, to anow numer-
ous normalpregnancies (Miihlbock, 1950 ; Miihlbock, van EbbenhorstTengbergen and van Rijssel, 1952) because these conditions are believed to be the most
favourable for induction of mammary carcinoma. Neither Little and Pearson
(1940) nor Bittner (1948) were able to confirm the favourable influence of force-
breeding. A direct relationship between increase in number of pregnancies with
normal lactation or survival age and mammary tumour incidence appears to be
questionable (PuUinger and Iversen, 1960) but no better standards for measuring incidence are yet available. Therefore the practice of rapid breeding has been
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followed in the experiments here recorded and only those females that had 3
or more litters have been included in the results.
No electron microscope studies have been made. As no biological evidence of
the agent had been found it was unlikely that virus particles would be plentiful
and therefore readily detected or, if seen, that they would necessarily represent
Bittiier's mammary tumour agent. Nor has any attempt been made to increase
the amount of this agent by culture in cells in vitro in these laboratories. No
accouiit of such studies elsewhere has been found. It is not known whether this
braiieh of the original C3H straiii carries the polyoma agent. No spontai-ieous
mammary tumours similar to those caused by the polyoma agent and described
by Clyde, Law and Dunn (1959) or by Stanton et al. (1959) have been observed
in this colony nor in any of the experimental mice.
The natural occurrence and forced production of adenomas (hyperplastic
nodules) to detect the mammary tumour agent in young mice were investigated.
To avoid repetition these observations and experiments are recorded with their
results.
RESULTS
Rili, breeding record,3 and mammary carcinoma
Aii ii-icidence of this tumour of 12 in 482 breeders or 2-o' per cent in the first
34 generations has been recorded (Pullinger, 1955). Among 544 breeders in
geiierations F.35 to F.52 it was 14 or 2-6 per cent (Pullinger and Iversen, 1960).
In the F.35 generation 6 mammary adenocarcinomas arose in 6 out of 67 breeders
thus giving a higher incidence thai-i had ever been found before. This rise might
have been due to increase in a persisting small amount of agent or to its more
recent acquisitioii. The attempt was made to breed from tumour-bearing females
in F.35 to look for tumour increase in sublines. As mammary carcinoma arose so
late in life at an average age of 19-6 months in these 6 females, it was by chance
that I subline, derived by direct descent, and 2 sublines, derived from siblings
of other tumour bearers, had been bred when the unusual high incidence was
i-ioted. All6tumour-bearingfemalesbelongedtodifferentsublinesinF.35,havinga
common ancestor far back in F.24. Neither this common ancestor nor any inter-
vei-iing progenitors had developed overt mammary carcinoma but the mother in
F.34 of one of the 6 tumour bearers in F.35 was found at necropsy and by bulk-
staining to have a microscopic adenocarcinoma of Type A (purely acinar) in a
first left nipple area. Her daughter developed an anaplastic carcinoma in the
second right nipple region at 16 months of age. A biopsy was done and three
and a halfmonths later theprimary had recurred. At necropsy massivepulmonary
metastases were found. Subline 1, directly descended from this tumour-bearing
female, was bred through 5 generations which included 39 effective breeders that
lived to the ages given in Table 1. None developed mammary carcinoma. Of the
two sublines derived from siblings of 2 of the other 5 tumour-bearing females,
one, subline VI, was bred for 9 generations and included 36 effective breeders that
lived to the agesgiven in Table 1. No mammary tumour arose in these descendants.
The third subline was bred for 2 generations with 7 effective breeders. None
developed this tumour. In assessing incidence, although records were kept of all
mated females, only those that had more than 2 litters and lived to 8 months or
,over have been considered effective. None that failed to reach these standards
developed mammary carcinoma. From the Table I of Pullinger and IversenTESTS FOR MAMMARY TUMOUR AGENT IN CA AND RIlIt MOUSE STRAINS 281
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(1960) it can be seen that the unusually high incidence found in F.35 was not
maintained in succeedi'ng generations whether breeding was restricted or not.
The survival ages in most later generations was not less than in F.35. Since the
reference data and Table I (Pullinger and Iversen, 1960) were compiled, 20 out
of 23 and 23 out of 25 breeders in F.53 and F.54 have died without tumours.
Theremaining 5 are 23 months ofage or over and are free oftumours. The instance
just recorded is the only one among a total of 26 mammary tumour bearers in
52 generations in which a mother and daughter were found with these tumours,
one microscopic and one overt. The great-grandmother of one female in F.37
with a mammary carcinoma also bore this type of tumour. The only siblings
found with overt mammary carcinoma were 2 out of 4 in F.49. Once previously
in F.13, one sisterdeveloped a macroscopic and one a microscopic carcinoma. No
other close relationships oftumour-bearing females were found.
C3H, Strain
Presumptive testsfor mammary tumour agent
While pedigree records were accumulating, some presumptive tests for agent
were done.
1. Extracts ofspleen derived fromsurplusC3H/ males inearly litters were made
by spinning a 10 per cent suspension of homogenised tissues for 15 minutes at
14M00 g. Intraperitoneal injections of 0-05 ml. of supernatant fluid were made
into each of 13RIII, femalesaged 3 to 4 weeks. All were subsequently force-bred.
Nine in the F.I generation and 3 in F.2 survived from 8 to 21 months afterbearing
3 or more litters. No mammary carcinoma arose (Table I).
2. An extract was later prepared from a mammary carcinoma in a CA breeder. Intraperitoneal injection of 0-5 ml. of supernatant fluid from a 10 per
cent suspension spun at 14-,000 g. were made into 9 RIII, females aged 3 to 4
weeks. All were subsequently force-bred. Six survived for 8 to 24 months after
bearing 3 or more litters. No mammary carcinoma arose (Table 1).
3. Twenty-nine RIII/ females were bom in the presence of, and were left
with 15C3Hfnursing mothers. Their own mothers were removed within, at most,
16 hours ofbirth. These F.I cross-suckledRIII, females and 6 oftheir F.2 progeny
were subsequently force-bred. Nineteen of the original 29 bore 3 or more litters
and lived for 8 to 26 months. One breederonlyofthe 19 in F.I developed aperianal
mammary carcinoma ofcompound organoid type at 9 months of age afterbearing
6 litters. Neither ofher two C3Hf foster mothers developed mammary carcinoma.
Six only of the pooled F.2 generation were reared and mated. They lived to the
ages given in Table 1, bore multiple litters, and none developed mammary carci-
noma.
4. It was previously reported that adenomatous mammary nodules were
found regularly in the mammae of young females under a year old in several
strains infected with milk-factor, with the exception of Strain A, but that none
was seen in young virgins or breeders under this age after the presumed exclusion
of agent (Pullinger, 1952, 1955). Precise figures for these nodules in the original
C3H (Andervont) strain infected withagent are not known. Nodules were observed
in two C3Hb substrains freed from agent in females of 15 months or older but
data for younger mice were not given (Jones, 1951). Thus no comparison can be
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;_1 virgii-i females aged II months was undertaken. Two ,570 iiipple areas of 0-7 CA
hyperplastic nodules were found in 570 nipple areas.
5. Use was made of a previously recorded observation that the pathogenic
action of the mammary tumour agent in respect ofadenoma ii-iduction ai-id some-
times of carcinoma could be stimulated to develop earlier in susceptible, iiifected,
castrate mice of either sex by means of a few large, repeated doses of oestrone
or oestradiol but that, using the same technique, none was found in mice of the
same strain that had beei-i freed of agent. Twelve C3H, females ovariectomised
at 2 months of age were given 2 doses of 400 p,g. oestradiol in acetone per cutem
at aii ii-iterval of 20 days. At 8 months of age the II survivors were killed and all
nipple areas bulk-stained and examined. Regression of physiological response
had occurred in all and no carcinoma or adenoma was found. When a similar
test was done on 10 C3H females (derived from another subline) infected with
agent, adenomas were found in all 10 (Pulliiiger, 1.947). Similarly 4 RIII, males
injected with spleen extracts and 13 males nursed with their sisters by C3H/
mothers were castrated, treated with 3 doses of 400 pg. oestrone and I dose of
400 pg. progesterone, and were killed at 8 months ofage and all fatpads examined
by bulk-staining. No adenoma or carcinoma was found. In previous similar
tests of RIII males carrying mammary tumour agent, adenomas were found in
28 and carcinoma in .9 out of 30 mice but in none out of 18 Rlllx males (without
agent) similarly treated (Pullinger, 1947). The susceptibility of the Rlllf mice
to agent was again tested intraperitoneally with CBA tumour extract. Ten out
of 13 RIII, sucklings developed mammary carcinoma after they had been force-
bred (Table 1). This CBA subline had previously been fouiid to carry the agent
(Pullinger, 1953).
C3Hf breeding record-s and mammary carcinoma
The overall incidence was 25-9 per cent (Pullinger and Iversen, 1960). These
tumours were distributed haphazard in sublines. Records including 3 generatiolis
of ancestors of 26 out of 28 of the tumour-bearing females were available for
pedigree analysis. The records of the great-grandmothers of 2 were unknown
owing to transfer of the original breeding litter to this laboratory, but neither
their mothers nor grandmothers had mammary carcinoma. None of the 26
remaining tumour bearers had 3 ancestors with these tumours in the direct line
of descent. Five pairs of mothers and daughters had tumours of this kind and one
of the latter had also a grandmother with mammary carcinoma. The only other
tumour-bearing relations were 8 females withgreat-grandmothers and 4withgrand-
mothers which had borne these tumours. The remaining 9 (about a third) had
no known progenitor with this carcinoma. These data reveal no evidence of
accumulation of mammary carcinoma in sublines.
COMMENT
Breeding records through II generations ofC3Hf and 52 generations ofRIII,
female mice have failed to provide evidence of an overall increase or an accumula-
tion of mammary carcinomas in any sublines such as is known to occur when the
mammary tumouragent is presentinitially even in small amount. In the combined
tests for presumptive evidence of the agent in C3H, mice I mammary carcinoma
arose in 43 RIII, test females that had been force-bred. Two adenomatous (hyper-
plastic) nodules were found in 570 nipple regions of 57 C3H, virgin females aged284 B. D. PULLINGER
11 months. These two observations, namely 1 mammary carcinoma in a young
cross-suckled breeder and 2 nodules in young virgin females, provide the only
evidence that could be construed as indicating that the mammary tumour agent
was responsible for all or part of the mammary carcinoma incidence in the C3H,
strain. The single adenocarcinoma in 43 RIJIf test mice could have arisen " spon-
taneously" independently of the experimental procedures. However, it arose
earlier, at 281 days, than any previously found in Rlllf breeders. The range for
the first 12 carcinomas in F.1 to F.34 was 389 to 753 days. In the present genera-
tions, F.35 to F.52, two of 14 adenocarcinomas were found at 327 and 330 days
of age. Thus with larger numbers of tumour-bearing mice a wider spread in age
incidence became evident. This seems a more likely explanation of the earlier
occurrence of this single carcinoma than that one only out of 43 RIIlf test mice
was infected by an agent derived from the C3H^ strain.
The value of the observation of 2 adenomatous nodules at 11 months of age
in 570 nipple regions cannot be assessed without further data about the earliest
age when they appear in this strain. In the RIII, mice none has been seen before
one year of age (Pullinger, 1952, 1955).
SUMMARY
1. Pedigree records of 11 generations ofC3H^ and of the last 18 generations of
RIJIf breeding females have failed to provide evidence of an accumulation of
mammary carcinoma on sublines.
2. No evidence of the mammary tumour agent of Bittner was found in tests
with injected spleen or tumour extracts nor any indisputable evidence among
susceptible agent-free cross-suckled young mice.
3. Experiments designed to stimulate the pathogenic activity ofthe mammary
tumour agent failed to reveal evidence of its presence.
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ADDENDUM (24.5.60).
Thanks to the kind collaboration of Professor M. G. P. Stoker and Dr. M. Sussman
of the M.R.C. Virology Unit, Glasgow, sample sera from RIJIf and C3Hf mice have
been tested for polyoma antibody. Haemagglutination inhibition titres over 1/320 were
found in both strains.